GLP1R and Parkinson disease: Piling evidence in animal models shows GLP-1 and structurally similar GLP-1 receptor (GLP-1R) agonists protect against neurodegenerative and neurovascular diseases including AD and Parkinson’s disease (PD; Erbil et al., 2019).